Fatty15 Crowned Best Cellular Health Supplement Brand 2026 in USA

In an impressive achievement, Fatty15 has claimed the title of Best Cellular Health Supplement Brand 2026 in the USA, as awarded by Global Health Pharma (GHP). This recognition underscores the essential role of strong cellular health in promoting overall wellness, emphasizing that robust cells contribute significantly to metabolic, immune, and cognitive functions.

The hallmark of Fatty15's success lies in its unique formulation of C150 (pentadecanoic acid), which is touted as the first new essential fatty acid identified in over ninety years. Scientific literature increasingly suggests that inadequate levels of C150 can lead to ferroptosis, a newly identified type of cellular death that accelerates aging and adversely affects various health aspects, including liver and heart function. Fatty15 stands apart in the supplement industry not just for its distinct offerings but also for its robust scientific backing, boasting over 150 peer-reviewed studies that validate its claims.

C150 is known for promoting a host of cellular benefits — more than 36 distinct advantages, to be precise. These include improvements in metabolic health, cognitive function, and red blood cell health. By actively engaging with key cellular pathways, C150 supports cellular resilience against age-related decline, activating AMPK while inhibiting mTOR, pathways that are crucial for longevity. Furthermore, it aids in repairing mitochondrial function, which tends to decline with age.

The GHP award reflects not only the scientific underpinnings of Fatty15 but also its considerable impact on users. Based on a survey of over 6,200 consumers, 70% reported perceivable benefits within just 16 weeks of use. Additionally, the brand boasts an impressive 95% monthly customer retention rate since its inception in 2021, with over 110,000 active subscribers. In early 2026, Fatty15 also received the TESTED by SuppCo Certification, achieving an excellent TrustScore of 9.88, placing it firmly within the top 1% of over 160,000 supplements evaluated.

Dr. Eric Venn-Watson, co-founder and co-CEO of Seraphina Therapeutics, voiced the importance of C150 in maintaining cellular integrity. He noted that recent studies substantiate that deficiencies in nutritional C150 could exacerbate cellular aging. The latest accolade for Fatty15 signifies not only the growing acknowledgment within the industry but also the global initiative to enhance well-being from the cellular level upwards.

This new accolade adds to Fatty15's expanding collection of awards, which include the GHP Global Excellence Award as the Best Longevity Supplement Brand of 2025, the Best Essential Fatty Acid Supplement Brand 2026, and the Mindful Award's Wellness Company of the Year 2026. Moreover, Seraphina Therapeutics has been recognized as the #1 fastest-growing supplement company in the 2025 Inc. 5000 list, illustrating its significant impact and growth trajectory.

About Seraphina Therapeutics: This innovative health and wellness company is dedicated to enhancing global health through the formulation of essential nutrients and longevity-supporting compounds, including its award-winning C150 supplement. Backed by a team of leading scientists, Seraphina Therapeutics is determined to redefine nutritional strategies, paving the way for breakthrough health products aimed at improving quality of life often lost over time. For further information, visit DiscoverC15.com and fatty15.com.

These claims have not been evaluated by the FDA. This product is not intended for the diagnosis, treatment, cure, or prevention of any disease.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.